BusinessCleartronic, Inc. (CLRI) Subsidiary VoiceInterop Signs Definitive Agreement Acquiring the Assets of CanniPlus Global, Inc.By Nasdaq OMXApr 24, 2018, 1:01 PM UTC
BusinessCB Scientific’s (CBSC) R & D Focuses on Opioid Crisis, a National Public Health EmergencyBy Nasdaq OMXOct 31, 2017, 12:00 PM UTC
BusinessSPR Therapeutics® Secures $25 Million in Series C FinancingBy Nasdaq OMXSep 12, 2017, 12:03 PM UTC
BusinessSPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and DevelopmentBy Nasdaq OMXSep 7, 2017, 1:13 PM UTC
BusinessSPR Therapeutics Awarded $6M Contract From the United States Department of Defense to Advance Non-Opioid Pain Relief TherapyBy Nasdaq OMXMay 15, 2017, 1:04 PM UTC
